Cepheid Expands Distribution in China


Sunnyvale, Calif. - Cepheid announced that it has executed a non-exclusive distribution agreement with Gene Company for distribution of Cepheid's products in the Clinical Research and Life Sciences markets in China and Hong Kong.

"Gene Company represents a significant quality distribution partner for a potentially large market," stated Ira Marks, Cepheid VP Worldwide Sales & Marketing. "This represents an additional step in strengthening our distribution capability in markets outside of the USA, Europe and Japan."

The agreement is a non-exclusive, 3-year term for distribution of Cepheid's SmartCycler Systems, accessories and OmniMix HS reagents across China and Hong Kong. Gene Company has been in business since 1992 with approximately US$35 million in sales in 2003. The company has 18 offices across China, including its Hong Kong headquarters, and employs over 250 people. Gene Company is a part of Gene Group Holdings, which consists of the following subsidiaries: Genetech -- an R&D laboratory facility for developing its own line of reagent products; ebiotrade -- currently the largest biotech portal in China http://www.ebiotrade.com; and Ecotech -- an instrument and reagent sales organization specifically targeting environmental and agricultural markets.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy